SEC Form D · filed January 3, 2022
Artax Biopharma, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Alan E. Walts · Cambridge, MADirectorRobert M. Armstrong, Ph.D · Cambridge, MADirectorDamia M. Tormo, Ph.D · Cambridge, MADirectorGino M. Santini · Cambridge, MADirectorJoseph M. Lobacki · Cambridge, MAExec · DirectorEdwin Kania · LOS ANGELES, CADirectorDrew Anwyll · Toronto, Ontario, CanadaDirectorQuentin Yarie · Toronto, Ontario, CanadaDirectorKen Deregt · New York, NYDirectorMark Reynoso · LOS ANGELES, CAExec · DirectorArne Brock-Utne · Lafayette, CADirectorWarren A. Heffelfinger · Lafayette, CAExec · DirectorRami Elghandour · Gaithersburg, MDDirectorDavid T. Lubner · Gaithersburg, MDDirectorAlan Young · Detroit, MIDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗